Member Info for busicat

Sharecast says "Convatec shares fell sharply on Tuesday after the Centers for Medicare & Medicaid Services in the US suggested to cut spending on skin-substitute products, citing "abusive pricing practices". " : (

EBITDA positive with 8 months not 18.

"EBITDA remains on track to turn positive on a run-rate basis by the end of FY2026." "Not even going to be Ebitda positive for another 18 months" We're now in FY 2026. FY 2025 ended 31 March.

Thanks for pulling this together Stephen.

I haven't checked your inputs or totals that will be very happy if your concluding paragraph is correct in estimating £4m current cash left. My observation is that you project forward to note current cash has us funded into November if cashburn continues at £500k pm and I wonder if you agree this means that's worst case on these calculations, since that seems to ignore further income receivable over those months?

For reference here's your last paragraph again:

"So, we might estimate 3.3m cash, plus £2.3m in drip-fed grant funding to come! Conservatively, we might estimate to have received 0.7m of the funding money so far. This would give GDR £4.0m. Assuming a cashburn of £500, 000 in April, May, June, and July GDR would have spent £2m, leaving us funded until *****November 2025****

Trades doing the talking here : )

1 Aug suspension warned on 10/7 not Carclo's fault and price has held, so seemingly market recognises that.

Lots of wisdom here (in this general article - not sprecific to GDR) on the value of patience for backers of transformative companies, which so many here, including myself, hope Genedrive is:

www.scottishmortgage.com/en/uk/individual-investors/insights/ic-article/sm-articles-2025-back-to-blue-sky-and-base-rates-10-years-on

I hope this soothes the nerves as we wait at least another couple of weeks...

LOL...race to the bottom. Question is whether at 6.40 we're on today's last lap. (Yes I know it's 2p, LTI. Just talking about today for now though.)

Whoops that turned up again faster than expected, so hopped out again. More relaxing that way.

Nice of LTI to show concern about my bad bargain yesterday st 8.5p, but I was satisfied to more than get my money back this morning.

Returning to see it offer me 8.0941 seemed too tempting, so I've risked another bad bargain and we'll see what Monday brings...maybe the chance for more folly. Happy weekend all!

Just capturing the big sells yesterday, reported today, for those who come to read this later:

25-Jul-25 12:20:00 24.88 23,971 Buy* 24.00 25.50 5,964 O

24-Jul-25 16:03:39 24.95 1,580,000 Unknown* 24.00 25.50 394.21k O

24-Jul-25 15:41:39 24.90 1,730,776 Unknown* 24.00 25.50 430.96k O

25-Jul-25 11:29:23 24.30 20,000 Sell* 24.00 25.50 4,860 O

I'm guessing the general sell off today might be related

Have we already discussed antidepressants (not for ourselves!) as the possible next tests in development?

I ask having just reviewed Gino's recent presentation at the Proactive One2One Investor Forum. Towards the end, he noted that other tests are in the pipeline, without saying what they are. But going back to his explanation of the overall benefit of pharmacogenetic testing, at 4mins in, although he didn't speak to the point, his slide illustrated antidepressants as the example and specified £823m as the implied UK cost of the trial and error approach. (Analgesics appeared next, but no associated quantification. )

https://www.proactiveinvestors.co.uk/companies/news/1073754/genedrive-ceo-on-rapid-genetic-testing-rollout-one2one-investor-forum.html

... or next leg down?

I've gone for option A, and popped a bit more in here at 8.49 but seem to remember hitting 7.20 in the last plummet, so holding back just in case

Does this mean you've cashed out again Roger?

£34.59k at 172.9326 for 09:30:29 when Offer was 172.50 says someone with deeper pockets than me agrees with us.

Daily progress seems to be confirming a re-rating trend : )

This is great for Ondo, vipHomeLink and Ting.

Makes Homelink offer more compelling, extends reach for Ondo to the smaller and medium insurers with Homelink doing the marketing and sales legwork, Ondo and Ting together make a more powerful combo which make sense to be reiterated elsewhere and this sets a good precedent - should raise sales for both.

Nice: profitability of £3.2m (Q2 2024: £(1.9)m) on an Last Twelve Months Adjusted EBITDA basis.

A dependable growth business with scalable recurring Revenue and profitable growth business model.

A steady share I plan to accumulate patiently while still under the radar.

Agree with GreenEyes and WHL

40.50 and 41 paid for 10k and 15k 20 mins ago - even better!

23-Jul-25 12:46:09 41.00 15,000 Buy* 37.00 40.00 6,150 O

23-Jul-25 12:43:33 40.50 10,000 Buy* 37.00 40.00 4,050 O

Here we go again...

Rejuvenation of price activity today could be a sign of renewed interest ahead of results for end of tomorrow and the 5 pm webinar I suppose?